Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Oncore Pharma Signs European Marketing Deal for Colorectal Cancer Test

Oncore Pharma Signs European Marketing Deal for Colorectal Cancer Test

Oct 10, 2019
|
staff reporter

NEW YORK — Oncore Pharma said today that it has partnered with Dutch medical testing firm BodyCheck to commercialize the ColonSentry colorectal cancer test in Belgium, the Netherlands, and Luxembourg in a deal valued at $61.8 million. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Letters Urge Review of Decision to End Coronavirus Grant

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

US Concerns Over BGI Testing in Middle East

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

Confidence Boost

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

Science Studies Describe Machine Learning Algorithm to Speed Mendelian Diagnoses, Safe Drug Response Gene, More

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.

May
27
Featured Webinar

Identifying Molecular Drivers of Cancer via Comprehensive Sequencing of a Large Cohort with Matched Germline and Clinical Data

Sponsored by
Discovery Life Sciences

M2Gen’s Oncology Research Information Exchange Network (ORIEN) Avatar Research Program collects and studies consented cancer patients’ biospecimens and companion clinical information for the development of improved oncology treatments. 

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

What's Popular?

In Molecular Diagnostics

  1. Head-to-Head Comparisons of Commercial SARS-CoV-2 MDx Tests Point to Few Differences in Accuracy

    Premium

  2. BioCore, SolGent, Seasun Get FDA Emergency Use Authorizations for Coronavirus Tests

  3. P23 Labs Receives FDA Emergency Use Authorization for SARS-CoV-2 Test

  4. SeqOne Looks to Support NGS-Based COVID-19 Testing to Accelerate Pandemic Screening, Tracing

    Premium

  5. Color Receives FDA Emergency Use Authorization for COVID-19 Test Using Isothermal Amplification

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.